The Allopharm company received a registration certificate for the original medical product ENTOMIX®

The Allopharm company received a registration certificate for the original medical product “ENTOMIX® hydrogel coating for inhibiting the growth of bacterial biofilms according to TU 32.50.50-006-72500079-2020”.

The registration certificate number is RZN 2020/12582.

ENTOMIX® hydrogel coating for inhibiting the growth of bacterial biofilms:

— contains a complex of antimicrobial peptides FLIP7 (defensins, cecropins, diptericins, proline-rich peptides)

— acts on both sensitive and antibiotic-resistant bacteria

— increases the effectiveness of medical procedures for cleaning the wound cavity or inflammation focus from bacteria

— provides moist wound management without hindering aeration, accelerates wound healing

— intended for use in the health care institutions, as well as at home

— can be used individually, or as an adjuvant to improve the effectiveness of antibiotic treatment

— does not cause bacterial resistance